The role of collaborative, multistakeholder partnerships in reshaping the health management of patients with noncommunicable diseases during and after the COVID-19 pandemic

• Type: Article in International Scientific Journal
• Date: 2021

Authors

Monaco, A (Author) Other; Blanco, AC (Author) Other; Cobain, M (Author) Other; Costa, E (Author) FFUP; Guldemond, N (Author) Other; Hancock, C (Author) Other; Onder, G (Author) Other; Pecorelli, S (Author) Other; Silva, M (Author) Other; Tournoy, J (Author) Other; Trevisan, C (Author) Other; Votta, M (Author) Other; Yfantopoulos, J (Author) Other; Yghemonos, S (Author) Other; Clay, V (Author) Other; Malvestiti, FM (Author) Other; De Schaetzen, K (Author) Other; Sykara, G (Author) Other; Donde, S (Author) Other

Journal

Title: Aging - Clinical and Experimental Research

Vol. 33

Pages: 2899-2907

ISSN: 1594-0667

Publisher: Springer Nature

Indexing

ISI Web of Knowledge - 8 Citations

Scopus - 9 Citations

Other information

Authenticus ID: P-00V-7YC

DOI: 10.1007/s40520-021-01922-y

Abstract (EN): Background Policies to combat the COVID-19 pandemic have disrupted the screening, diagnosis, treatment, and monitoring of noncommunicable (NCD) patients while affecting NCD prevention and risk factor control. Aims To discuss how the first wave of the COVID-19 pandemic affected the health management of NCD patients, identify which aspects should be carried forward into future NCD management, and propose collaborative efforts among public-private institutions to effectively shape NCD care models. Methods The NCD Partnership, a collaboration between Upjohn and the European Innovation Partnership on Active and Healthy Ageing, held a virtual Advisory Board in July 2020 with multiple stakeholders; healthcare professionals (HCPs), policymakers, researchers, patient and informal carer advocacy groups, patient empowerment organizations, and industry experts. Results The Advisory Board identified barriers to NCD care during the COVID-19 pandemic in four areas: lack of NCD management guidelines; disruption to integrated care and shift from hospital-based NCD care to more community and primary level care; infodemics and a lack of reliable health information for patients and HCPs on how to manage NCDs; lack of availability, training, standardization, and regulation of digital health tools. Conclusions Multistakeholder partnerships can promote swift changes to NCD prevention and patient care. Intra- and inter-communication between all stakeholders should be facilitated involving all players in the development of clinical guidelines and digital health tools, health and social care restructuring, and patient support in the short-, medium- and long-term future. A comprehensive response to NCDs should be delivered to improve patient outcomes by providing strategic, scientific, and economic support.

Language: English

Type (Professor's evaluation): Scientific

No. of pages: 9